Niche CRO Focus Certerra is a specialized contract research organization offering high-content screening in the mouse brain for neuroscience drug discovery, presenting a clear opportunity to engage pharma/biotech companies seeking preclinical to clinical translational insights in neurology.

Translational Advantage The company highlights quantitative correlations between mouse model data and human pharmacology, suggesting value in evidencing predictability from animal studies to human outcomes, a compelling angle for partners aiming to de-risk early asset programs.

Brain Disorder Coverage Certerra’s methods apply across neurodevelopmental, psychiatric, and neurodegenerative disorders, indicating broad market applicability and multiple potential target indications for collaboration and sponsored projects.

Small Team, Boutique agility With a lean team (2-10 employees) and boutique CRO positioning, there is an opportunity to position as a flexible, fast-moving partner for mid-size biotech firms seeking specialized CNS screening without the overhead of large CROs.

Growth and Visibility Revenue is currently under one million, signaling room to scale; partner outreach can emphasize capability expansion, co-development potential, and milestone-based engagements to accelerate growth and showcase track record.